3. Avibactam/ceftazidime – drug summary. 2024. https://pdr.net/drug-summary/Avycaz-avibactam-ceftazidime-3692
4. Carmeli Y, Armstrong J, Laud PJ, et al. Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomized, pathogen-directed, phase 3 study. Lancet Infect Dis. 2016:661-73.
5. Qin X, Tran BG, Kim MJ, et al. A randomized, double blind, phase 3 comparing the efficacy and safety of ceftazidime/ avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalized adults in Asia. International Journal of Antimicrobial Agents. 2017;49:579-88.
6. Mazuski JE, Gasink LB, Armstrong J, et al. Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double blind, phase 3 program. Clinical Infectious Disease. 2016;62:1380-89.
7. Torres A, Zhang N, Pachl J, et al. Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomized, double blind, phase 3 non-inferiority trial. Lancet Infect Dis. 2018;18:285-85.
8. Bradley J, Broadhurst H, Cheng K, et al. Safety and efficacy of ceftazidime-avibactam plus metronidazole in the treatment of children ≥3 months to <18 years with complicated intra-abdominal infection: results from a phase 2, randomized, controlled trial. The Pediatric Infectious Disease Journal. 2019;38:816-24.
10. Kementerian Kesehatan Republik Indonesia. Daftar Obat Esensial Nasional. 2019. http://farmalkes.kemkes.go.id/unduh/kepmenkeshk-01-07-menkes-688-20192019daftar-obat-esensial-nasional/
11. Australian Product Information - Zavicefta®2000/500 (ceftazidime/avibactam). https://www.tga.gov.au/sites/default/files/auspar-ceftazidime-avibactam-200224-pi.pdf
12. Full Prescribing Information Avycaz (ceftazidime and avibactam). https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206494s005,s006lbl.pdf